The 3rd Chronic Kidney Disease Drug Development (CKD3) Summit is the industry’s definitive forum dedicated to developing more innovative, targeted and clinically successful drugs to more meaningfully address chronic kidney disease is back!

Gathering cross-industry experts from nephrology, cardiology, and endocrinology to analyze and overcome challenges in diabetic kidney and rare glomerular disease drug development, CKD3 is the must-attend forum for focused discussion and actionable insights to further CKD drug development.

From foundational science for target identification through to patient recruitment and costings of approved drugs in orphan indications, hear from over 30 speakers and gain candid insights on the latest results to inform your pipeline from concept to clinical trials.